Separation and noise anxiety in dogs: does dog-appeasing pheromone (diffuser/collar) versus placebo reduce anxiety signs? — POSSIBLE

In dogs with separation or noise anxiety, does a dog-appeasing pheromone diffuser/collar vs placebo reduce anxiety signs?

Shelf #670 · gate-verified and displayed under the developer's blinded-trial rule

POSSIBLE: Two placebo-controlled trials carded here favour dog-appeasing pheromone (DAP), each in a narrow setting. For separation-related signs, Kim 2010 (PMID: 20592826) — a randomised controlled trial (publication type) with blinding recorded in its MeSH (Double-Blind Method) — compared DAP (n = 24) with placebo (n = 19) in hospitalised dogs and found overall amelioration of separation-related signs, with significant decreases in elimination (P = 0.038), excessive licking (P = 0.005) and pacing (P = 0.017). For noise anxiety, Landsberg 2015 (PMID: 26311736) tested a DAP collar against a placebo collar in 24 beagles exposed to a thunderstorm recording and found global and active fear-and-anxiety scores significantly improved versus placebo on both test days; its record establishes blinding (MeSH: Double-Blind Method) but does not state randomisation (dogs were divided into groups balanced on fear score). Design class (a): randomisation and blinding are established by a carded record answering the shelf's own comparison and population — Kim 2010, randomised (publication type) and blinded (MeSH Double-Blind Method), DAP versus placebo in dogs showing separation-related signs. The stamp is POSSIBLE, not higher, because neither trial studied the common home presentation directly: the separation trial was in hospital inpatients rather than dogs with separation anxiety at home, the noise trial was a laboratory thunderstorm simulation in beagles rather than pet dogs in real storms or fireworks, both trials are small, and a systematic review of the earlier pheromone literature (Frank 2010, PMID: 20550445) judged most of it insufficient evidence. The tested preparations are the dog-appeasing pheromone products used in the trials (generic name used throughout; the collar trial's product class is named in its record as a dog-appeasing pheromone collar). Boundary: alpha-casozepine for canine anxiety is built Shelf #669 — a different intervention, not used here. Drafted Nov 10, 2026 (VetMed build, topic #670); all figures from the abstracts fetched and verified at drafting.

Kim 2010: dog-appeasing pheromone beat placebo for separation-related signs in 43 hospitalised dogs — significant decreases in elimination (P = 0.038), excessive licking (P = 0.005) and pacing (P = 0.017)

Randomized Controlled Trial (publication type); blinding recorded in the record's MeSH (Double-Blind Method)

Who: Dogs: 43 dogs hospitalised in veterinary clinics, showing separation-related behavioural signs of hospitalisation; a dog-appeasing pheromone (DAP) treated group (n = 24) was compared with a placebo control group (n = 19). Ten typical separation-related behavioural signs were assessed (including vigilance and anorexia). The record does not specify the pheromone delivery device in its abstract.

Result: There was overall amelioration of the signs, except 'vigilance' and 'anorexia', in the DAP-treated dogs compared with placebo. Marked decreases were noted in elimination (P = 0.038), excessive licking (P = 0.005) and pacing (P = 0.017). The authors conclude DAP could decrease separation-induced anxiety, distress and fear in inpatients and possibly facilitate recovery in hospitalised dogs.

Watch out: The population is hospital inpatients whose signs arise from separation-by-hospitalisation, not pet dogs with diagnosed separation anxiety left alone at home — the setting this shelf is usually asked about — and only 3 of the 10 assessed signs are reported as individually significant, with no absolute sign frequencies in the abstract, so the size of the benefit cannot be quantified from the record. The delivery device (diffuser versus collar) is not specified in the abstract.

Kim YM, Lee JK, Abd el-Aty AM, Hwang SH, Lee JH, Lee SM. Can Vet J. 2010;51(4):380-4. PMID: 20592826. Registry ID: none in the record. MeSH: Animals · Antidepressive Agents/therapeutic use* · Anxiety, Separation/drug therapy* · Behavior, Animal/drug effects · Dog Diseases/drug therapy*, psychology · Dogs · Double-Blind Method · Female · Male · Pheromones/therapeutic use* · Treatment Outcome

Landsberg 2015: dog-appeasing pheromone collars reduced sound-induced fear and anxiety versus placebo collars in 24 beagles — global and active scores significantly improved during and after thunder on both test days

Controlled Clinical Trial (publication type), placebo-controlled; blinding recorded in the record's MeSH (Double-Blind Method); the record does not state randomisation

Who: Dogs: 24 beagle dogs, naïve to the test, in a laboratory model of thunderstorm simulation. Dogs were divided into two treatment groups (dog-appeasing pheromone collar and placebo collar), balanced on their fear score in response to a thunderstorm recording, then exposed to two further thunderstorm simulation tests on consecutive days. Dogs were video-assessed by a trained observer on a 6-point scale for active, passive and global (combined) fear and anxiety.

Result: Both global and active fear-and-anxiety scores were significantly improved during and following thunder compared with placebo on both test days. The pheromone group significantly decreased global fear and anxiety across 'during' and 'post' thunder times compared with baseline; there was no significant improvement in the placebo group from baseline on the test days (the placebo made no difference to scores from baseline). The pheromone group also showed significantly greater use of the hide box at any time with increased exposure compared with the placebo group.

Watch out: A laboratory thunderstorm recording in 24 beagles is a model of noise anxiety, not pet dogs reacting to real fireworks or storms at home, and the abstract reports significance without absolute score values, so the size of the effect is not quantifiable from the record. Allocation was by balancing on fear score rather than a stated random method. Only the collar preparation was tested here; diffuser performance for noise anxiety rests on the uncontrolled fireworks record noted in the synthesis, not on a placebo-controlled trial.

Landsberg GM, Beck A, Lopez A, Deniaud M, Araujo JA, Milgram NW. Vet Rec. 2015;177(10):260. PMID: 26311736. Registry ID: none in the record. MeSH: Animals · Anxiety/drug therapy*, etiology · Behavior, Animal/drug effects* · Dogs/psychology* · Double-Blind Method · Fear/drug effects* · Female · Male · Noise/adverse effects* · Pheromones/pharmacology* · Video Recording · Weather

Synthesis: placebo-controlled trials favour dog-appeasing pheromone in hospitalised separation signs and in a laboratory thunder model, but no placebo-controlled trial covers home separation anxiety or real-world noise events — POSSIBLE

Synthesis

Who: Synthesis of the two cards above: Kim 2010 (43 hospitalised dogs, DAP versus placebo, separation-related signs) and Landsberg 2015 (24 beagles, DAP collar versus placebo collar, simulated thunderstorm).

Result: (1) Separation-related signs: overall amelioration on DAP versus placebo, with significant decreases in elimination (P = 0.038), excessive licking (P = 0.005) and pacing (P = 0.017) in hospitalised dogs (Kim 2010). (2) Noise anxiety: global and active fear-and-anxiety scores significantly better on DAP collar than placebo collar during and after simulated thunder on both test days, with greater hide-box use (Landsberg 2015). (3) Neither carded trial enrolled the typical home patient — dogs with separation anxiety at home, or pet dogs during real fireworks/storms — so the benefit in those settings is extrapolated, not directly shown.

Watch out: One-home check at drafting: neither PMID 20592826 nor 26311736 appears in any other pack on disk. Records deliberately not carded as claim-carriers: Gaultier 2005 (PMID: 15849342), a randomised blind trial in 67 dogs with separation-related disorders comparing DAP with clomipramine — no placebo group (omitted for ethical reasons per its record), owners' overall assessment found no significant difference between the two treatments; it answers a different (active-comparator) question. Sheppard & Mills 2003 (PMID: 12708592), an open, uncontrolled clinical trial of a DAP diffuser in 30 dogs fearful of fireworks, reported owner-rated improvement in 9 of 14 signs — with no control group it cannot separate pheromone effect from expectation and time. Frank 2010 (PMID: 20550445), a systematic review of pheromone studies to December 2008, found insufficient evidence for DAP in noise phobia and most other uses; both carded trials postdate its search window. An owner-perception study of long-lasting DAP devices (PMID: 35011228) had no placebo group and found improvement in all groups with no difference between devices. Boundary: alpha-casozepine (Shelf #669) is a different intervention and none of its records is used here.

Synthesis of Kim YM et al. PMID: 20592826; Landsberg GM et al. PMID: 26311736. Registry IDs as on the individual cards.

Back to the library index · VetMed home

VetMed is an educational resource, not veterinary advice.